Breaking News Instant updates and real-time market news.

ACB

Aurora Cannabis

$8.84

0.33 (3.88%)

06:33
04/17/19
04/17
06:33
04/17/19
06:33

Aurora Cannabis initiated with a Buy at BofA/Merrill

BofA/Merrill analyst Christopher Carey initiated Aurora Cannabis with a Buy and $11 price target saying it has a low cost production model, can protect margins in an oversupplied market, and the ability to serve a global market. Aurora also has long-time consumer investor, Nelson Peltz, as a Strategic Advisor which should accelerate partnership transactions, Carey wrote in a note to investors.

ACB Aurora Cannabis
$8.84

0.33 (3.88%)

04/08/19
COWN
04/08/19
NO CHANGE
COWN
Cowen moderates near-term expectations for cannabis group on supply constraints
After hosting investor meetings with the management of Tilray (TLRY), Cowen analyst Vivien Azer said that Canada clearly remains supply constrained and that Tilray, with its asset-light approach, is overexposed to this supply tightness. Independent of commentary from the meetings with Tilray, Azer lowered her revenue estimates throughout her Canadian cannabis coverage as her current read suggests that Q1 growth will likely be modest. Despite her moderation of her near-term expectations, Azer keeps Outperform ratings on Aurora Cannabis (ACB), Canopy Growth (CGC) and Tilray (TLRY) and maintains a Market Perform rating on Cronos (CRON).
03/14/19
COWN
03/14/19
NO CHANGE
COWN
Narrow U.S. cannabis bills have better prospects than broad ones, says Cowen
Cowen analyst Jaret Seiberg said it is hard for him to see a scenario in the 116th Congress in which Senate Majority Leader Mitch McConnell holds a vote on legislation to fully legalize cannabis, as too many senators see no political upside for McConnell to schedule such a vote. Given this view, Seiberg believes that prospects are better for narrower bills that could get attached to spending packages and other measures than for broader bills that would legalize recreational use. Of the narrower bills introduced in the U.S. so far, Seiberg believes the SAFE Act on cannabis banking has the best shot before the 2020 election. Publicly traded companies in the cannabis space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), MediPharm Labs (MLCPF) and Tilray (TLRY).
03/13/19
03/13/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Carnival (CCL) upgraded to Buy from Neutral at Goldman Sachs analyst Stephen Grambling citing the company accelerating its net unit growth from 2.5% in the last 3 years to 5% over the next 3 years and also believes that concerns about net yields in Europe are overblown. 2. Sanderson Farms (SAFM) upgraded to Neutral from Underweight at JPMorgan with analyst Ken Goldman saying he now views the stock's upside/downside risk as balanced. 3. Axis Capital (AXS) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Meyer Shields saying Axis is positioned for strong underwriting improvement. 4. Broadridge (BR) upgraded to Outperform from Market Perform at Raymond James with analyst Patrick O'Shaughnessy saying he believes Broadridge's current valuation offers investors an attractive entry point into a differentiated, high barrier to entry business. 5. Aurora Cannabis (ACB) upgraded to Buy from Hold at GMP Securities with analyst Martin Landry saying new high profile strategic advisor Nelson Peltz could be "instrumental" in facilitating partnership talks with large consumer packaged goods companies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/13/19
MITR
03/13/19
UPGRADE
Target $15
MITR
Buy
Aurora Cannabis upgraded to Buy from Hold at GMP Securities
GMP Securities analyst Martin Landry upgraded Aurora Cannabis to Buy from Hold and raised his price target to $15 from $9.50. In a research note to investors, Landry says new high profile strategic advisor Nelson Peltz could be "instrumental" in facilitating partnership talks with large consumer packaged goods companies. Additionally, the analyst says its fully-licensed Bradford and Aurora Sky facilities should alleviate inventory concerns.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.